TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
Evomed AB
Closing information (x1000 DKK)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
1,386
|
1,331
|
1,455 |
| Financial expenses |
0
|
1
|
5 |
| Earnings before taxes |
75
|
90
|
-47 |
| EBITDA |
91
|
108
|
-23 |
| Total assets |
328
|
359
|
315 |
| Current assets |
296
|
308
|
245 |
| Current liabilities |
94
|
77
|
108 |
| Equity capital |
234
|
282
|
208 |
| - share capital |
32
|
34
|
33 |
| Employees (average) |
1
|
1
|
3 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
71.3%
|
78.6%
|
66.0% |
| Turnover per employee |
1,386
|
1,331
|
485 |
| Profit as a percentage of turnover |
5.4%
|
6.8%
|
-3.2% |
| Return on assets (ROA) |
22.9%
|
25.3%
|
-13.3% |
| Current ratio |
314.9%
|
400%
|
226.9% |
| Return on equity (ROE) |
32.1%
|
31.9%
|
-22.6% |
| Change turnover |
99
|
-132
|
-310 |
| Change turnover % |
8%
|
-9%
|
-18% |
| Chg. No. of employees |
0
|
-2
|
0 |
| Chg. No. of employees % |
0%
|
-67%
|
0% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.